Arcturus Therapeutics Holdings Inc. (ARCT)

NASDAQ: ARCT · Real-Time Price · USD

7.53

+0.75 (11.06%)

At close: Jan 12, 2026, 4:00 PM EST

7.66

+0.13 (1.73%)

Pre-market: Jan 13, 2026, 5:56 AM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Messenger Ribonucleic Acid Medicines	152.31M	Log In	Log In	Log In	Log In	Upgrade
Messenger Ribonucleic Acid Medicines Growth	-8.69%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
United States	152.31M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-8.69%	Log In	Log In	Log In	Log In	Upgrade